findmyKOL
Clinical trialNCT04068597RecruitingPhase 1/PHASE2Interventional

Study to Evaluate CCS1477 (Inobrodib) in Haematological Malignancies

SponsorCellCentric Ltd.Enrollment250Acute Myeloid LeukemiaHaematological MalignancyHigher-risk Myelodysplastic SyndromeMultiple MyelomaNon Hodgkin LymphomaPeripheral T Cell Lymphoma
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

39 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

France
  • Institute Bergonie

    Bordeaux, France

    Completed
  • Gustave Roussy

    Villejuif, France

    Completed
Spain
  • Hospital Germans Trias I Pujol/ Ico Badalona

    Badalona, Spain

    Recruiting
  • Hospital Clínic de Barcelona

    Barcelona, Spain

    Recruiting
  • Ico L'Hospitalet (instituto Catalán de Oncología)

    Barcelona, Spain

    Recruiting
  • University Hospital Vall D'Hebron

    Barcelona, Spain

    Completed
  • Ciocc Hospital Universitario Hm Sanchinarro

    Madrid, Spain

    Completed
  • Hospital Infanta Leonor

    Madrid, Spain

    Recruiting
  • Hospital Universitario 12 de Octubre

    Madrid, Spain

    Recruiting
  • Hospital Universitario Gregorio Marañón

    Madrid, Spain

    Recruiting
  • Hospital Universitario Ramón Y Cajal

    Madrid, Spain

    Recruiting
  • Hospital Universitario de la Princesa

    Madrid, Spain

    Recruiting
  • Universidad de Navarra

    Pamplona, Spain

    Recruiting
  • Hospital Universitario Y Politécnico la Fe de la Comunidad Valenciana

    Valencia, Spain

    Recruiting
Sweden
  • Karolinska Comprehensive Cancer Center

    Stockholm, Sweden

    Completed
United Kingdom
  • the Royal Marsden

    Sutton, Surrey, United Kingdom

    Recruiting
  • the Clatterbridge Cancer Centre Nhs Foundation Trust,

    Bebington, United Kingdom

    Gillian Brearton, MD
    Recruiting
  • University Hospitals Bristol

    Bristol, United Kingdom

    Recruiting
  • University Hospital of Wales

    Cardiff, United Kingdom

    Recruiting
  • Royal Derby Hospital

    Derby, United Kingdom

    Firas Al-Kaisi, MD
    Recruiting
  • Western General Hospital

    Edinburgh, United Kingdom

    Recruiting
  • Gartnavel General Hospital

    Glasgow, United Kingdom

    Recruiting
  • Leicester Royal Infirmary

    Leicester, United Kingdom

    Recruiting
  • Imperial College

    London, United Kingdom

    Recruiting
  • Nihr University College London Clinical Research Facility

    London, United Kingdom

    Recruiting
  • Sarah Cannon Research Institute Uk

    London, United Kingdom

    Recruiting
  • St Bartholomew'S Hospital

    London, United Kingdom

    Recruiting
  • the Christie Hospital

    Manchester, United Kingdom

    Recruiting
  • Newcastle Upon Tyne Hospitals

    Newcastle upon Tyne, United Kingdom

    Recruiting
  • Nottingham University Hospitals Nhs Trust

    Nottingham, United Kingdom

    Recruiting
  • Cancer and Haematology Centre

    Oxford, United Kingdom

    Recruiting
  • University Hospital of Southampton

    Southampton, United Kingdom

    Recruiting
  • Royal Stoke University Hospital

    Stoke-on-Trent, United Kingdom

    Recruiting
United States
  • Emory Winship Cancer Institute

    Atlanta, Georgia, United States

    Dr Nisha Joseph, MD
    Recruiting
  • Community Health Network

    Indianapolis, Indiana, United States

    Pablo M Bedano, MD
    Recruiting
  • the Center for Cancer and Blood Disorders (ccbd)

    Bethesda, Maryland, United States

    Victor Priego, MD
    Recruiting
  • Nebraska Cancer Specialists

    Omaha, Nebraska, United States

    Stefano Tarantolo, MD
    Recruiting
  • University of Nebraska Medical Center

    Omaha, Nebraska, United States

    Sarah Holstein, MD
    Recruiting
  • Penn Medicine - Abramson Cancer Center Perelman

    Philadelphia, Pennsylvania, United States

    Dan Vogl, MD
    Recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
9 Aug 2019
Primary completion
31 Mar 2027
Completion
31 Mar 2027
Last update posted
24 Jun 2026
Registered enrollment
250
Registry id
NCT04068597

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.